Background:
The Berlin-based B_PROUD study was designed to assess the effect of Mobile Stroke Unit (MSU) dispatch among ischemic stroke and transient ischemic attack (TIA) patients without contraindications to reperfusion treatments. However, a large proportion of patients for whom the MSU was dispatched did not ultimately receive MSU care. We estimated the causal effect of additional MSU care on 3-month functional outcomes among B_PROUD patients for whom an MSU was dispatched.
Methods:
We used data from the B_PROUD study (1 February 2017-8 May 2019). Given the presence of exposure–outcome unmeasured confounding, we used the front-door formula to identify the distribution of modified Rankin scale (mRS) outcomes under two hypothetical interventions: (1) receiving additional MSU care and (2) only receiving conventional care. We considered time from dispatch to thrombolysis as the full mediator, and adjusted for exposure–mediator and mediator–outcome confounding. We used a parametric estimator to estimate common odds ratio (cOR) and 95% bootstrapped confidence intervals (CI).
Results:
We included in total 768 ischemic stroke/TIA patients with MSU dispatch. The MSU was cancelled for 180 (23%) patients, while 588 (77%) received MSU care. The unadjusted association between care group and mRS favored conventional care (cOR=1.7, 95% CI=1.2-2.3); however, after applying the front-door formula, the mRS distribution favored MSU care (cOR=0.88, 95% CI=0.81-0.96).
Conclusions:
Receiving MSU care was associated with better functional outcomes than conventional care only, compatible with the hypothesized beneficial effect of MSU care on post-stroke outcomes, among stroke and TIA patients without contraindications to reperfusion treatments.